Home-Based Shi's Knee Daoyin Exercise for Knee Osteoarthritis: A Randomized Controlled Pilot Trial
Kun Xu,Jiefan Zhang,Wei Ma,Yongyu Wang,Bo Chen,Ningyang Gao,Jian Pang,Hongsheng Zhan
DOI: https://doi.org/10.2147/jpr.s469176
IF: 2.8319
2024-09-01
Journal of Pain Research
Abstract:Kun Xu, 1, 2 Jiefan Zhang, 1, 2 Wei Ma, 1, 2 Yongyu Wang, 1, 2 Bo Chen, 1, 2 Ningyang Gao, 1, 2 Jian Pang, 1, 2 Hongsheng Zhan 1, 2 1 Shi's Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China; 2 Institute of Traumatology & Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai, People's Republic of China Correspondence: Hongsheng Zhan; Jian Pang, Email ; Objective: Shi's Knee Daoyin (SKD) exercise is a treatment derived from Traditional Chinese exercise (TCE) specifically designed for lower limb health care. This study aimed to assess the feasibility of conducting a randomized controlled trial to explore the effectiveness of SKD exercise in treating knee osteoarthritis (KOA). Methods: Participants were randomized to receive Health Education (HE) or SKD exercise. The primary outcomes were feasibility and safety outcomes, including participant recruitment rate, retention rate, as well as adherence to intervention. The secondary outcomes included Visual Analogue Scale (VAS) scores for pain, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, the 20-Meter Walk Test (20-MWT) and the 5-times Chair-Stand Test (5-CST). Results: The results indicate that out of 89 individuals invited to participate in the study, 72 were eligible and agreed to participate, resulting in a recruitment rate of 80.9%. All participating patients completed the follow-up and were included in the analysis; no patients dropped out of the study due to adverse events. The secondary outcome measures showed that after twelve weeks of treatment, the VAS score, WOMAC total score, WOMAC pain score, WOMAC stiffness score, and WOMAC function score of patients in the HE group and SKD group all improved, but the improvement was more significant in the SKD group. The 20-MWT of SKD group after treatment was significantly shorter than before treatment ( P < 0.001); There was no significant difference in 20-MWT between the HE group and baseline after treatment. The performance of the two groups of patients improved in 5-CST, but there was no statistical difference between the two groups after treatment ( P =2.439). Conclusion: This study evaluated the feasibility and effectiveness of home-based SKD exercise intervention in alleviating symptoms in patients with symptomatic KOA, providing valuable information for designing an appropriate randomized controlled study. Keywords: knee osteoarthritis, pilot, exercise, randomized controlled trial Knee osteoarthritis (KOA) is a prevalent joint disease among middle-aged and elderly patients, impacting all tissue components within and surrounding the joint. 1 KOA is characterized by cartilage degeneration, subchondral bone remodeling, 2 meniscal degeneration, 3,4 inflammation and fibrosis of both infrapatellar fat pad and synovial membrane that are involved in pain. 5 Factors contributing to the development of OA include age, joint trauma, other joint diseases, and overweight/obesity. 6 Moreover, KOA causes a low health-related quality of life by negatively affecting psychological and physical wellbeing. 7,8 It is the primary cause of disability with a negative impact on the physical and mental health of people across the globe. 9 Based on epidemiological statistics, the incidence rate of KOA sharply increases with age. 10 The increasing incidence of OA has globally led to substantial health and economic burden; 11 specifically in China, where, the number of aging population has been rapidly growing. 12 China has the largest global population, besides, its national population is rapidly aging; the rate of aging population (≥60 years) is predicted at 25.3% in 2030, and over 30% in 2050. 13 According to a 2014 national population-based survey in China, the prevalence rate of symptomatic KOA was at approximately 8.1% among Chinese residents aged 45 years, and significantly increased with advancing age. 14 Nonetheless, to our knowledge, no effective disease-modifying therapy for KOA has been reported. Existing treatments are available to reduce pain, improve joint mobility, and optimize survival and quality of life. Although pharmacological treatment can effectively relieve pain and improve mobility in KOA, accumulating evidence reveals that long-term use of pharmacotherapy and intra-articular injections may lead to severe undesirable side effects, including gastroin -Abstract Truncated-
clinical neurology